BRANDY BALLARD: Open Payments
NPI 1174621478 · WINCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 17 payments from 6 companies in 2025. Trend: 2023 $548 · 2024 $348 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $156 |
| Novo Nordisk Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, QULIPTA, CAPLYTA, Auvelity, FARXIGA, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
